Intersect ENT Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
Intersect ENT (XENT) Tops Q3 EPS by 10c
November 2, 2020 7:05 AM ESTIntersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $21.8 million.
Outlook:
As previously announced, due to the continued uncertainties resulting from the... More
